Soy Lecithin vs Mono- and Diglycerides: which is worse?

What is Soy Lecithin?

Soy lecithin is a phospholipid mixture extracted from soybeans during oil processing, primarily composed of phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol. It is one of the most widely used food emulsifiers globally. Most commercial soy lecithin is derived from genetically modified soybeans, though organic varieties are available.

What is Mono- and Diglycerides?

Mono- and diglycerides are emulsifiers derived from glycerol and fatty acids, most commonly sourced from soybean, palm, or sunflower oil. They are partial glycerides that exist between monoglycerides (one fatty acid chain) and diglycerides (two chains). They are chemically similar to fats but are not classified as trans fats even when made from partially hydrogenated sources.

Documented risks

Soy Lecithin: Generally recognized as safe. Soy lecithin is highly refined, and most soy proteins that trigger allergies are removed during processing; however, highly soy-allergic individuals may react. EFSA conducted a safety re-evaluation in 2017 and confirmed its safety at current use levels. The majority of commercial soy lecithin comes from GMO soybeans, which some consumers prefer to avoid. No major toxicological risks have been identified at normal dietary exposure levels.

Mono- and Diglycerides: Generally recognized as safe at typical food levels. However, mono- and diglycerides can be derived from partially hydrogenated oils, meaning they may carry trace trans fats that do not appear on the trans fat label because they are classified as emulsifiers, not fats. Some researchers have noted this labeling gap. A 2019 study published in Lipids in Health and Disease noted potential concerns with industrial trans fatty acids in these additives. For most consumers, exposure is low, and regulatory agencies including FDA and EFSA consider them safe at permitted levels.